Atara Biotherapeutics, Inc.

Historical 13F Holders

Symbol
ATRA
CUSIP
046513107
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 1 15.0 $215.00
2024 Q4 2 63.0 $839.00
2024 Q3 1 35.0 $285.00
2024 Q2 5 182 k $1.51 M
2024 Q1 88 87.3 M $60.7 M
2023 Q4 97 69.3 M $35.5 M
2023 Q3 119 88.2 M $131 M
2023 Q2 127 90.5 M $146 M
2023 Q1 131 103 M $298 M
2022 Q4 146 105 M $345 M
2022 Q3 161 100 M $378 M
2022 Q2 139 99.8 M $778 M
2022 Q1 153 97.9 M $910 M
2021 Q4 145 95.6 M $1.51 B
2021 Q3 144 89.7 M $1.61 B
2021 Q2 149 86.0 M $1.34 B
2021 Q1 154 86.7 M $1.24 B
2020 Q4 162 87.6 M $1.72 B
2020 Q3 149 83.8 M $1.09 B
2020 Q2 131 77.8 M $1.13 B
2020 Q1 121 63.0 M $536 M
2019 Q4 127 62.0 M $1.02 B
2019 Q3 124 59.0 M $833 M
2019 Q2 134 50.5 M $1.01 B
2019 Q1 131 48.9 M $1.94 B
2018 Q4 128 48.8 M $1.69 B
2018 Q3 127 47.1 M $1.95 B
2018 Q2 143 47.0 M $1.73 B
2018 Q1 131 43.9 M $1.71 B
2017 Q4 91 29.9 M $542 M
2017 Q3 86 26.6 M $441 M
2017 Q2 92 25.7 M $360 M
2017 Q1 90 24.1 M $496 M
2016 Q4 89 23.3 M $331 M
2016 Q3 77 22.4 M $479 M
2016 Q2 75 21.8 M $493 M
2016 Q1 73 19.8 M $377 M
2015 Q4 94 19.3 M $510 M
2015 Q3 94 20.1 M $644 M
2015 Q2 77 13.2 M $696 M
2015 Q1 54 11.2 M $462 M
2014 Q4 42 6.76 M $173 M